J&J consumer skin care sales top $500 mil. in 1995 -- analysts meeting.
This article was originally published in The Rose Sheet
Executive Summary
J&J UNIFYING NEUTROGENA/ORTHO DERM PROFESSIONAL SALES UNDER ORTHO management in anticipation of the launch of Ortho Dermatologics' antiwrinkling agent Renova (tretinoin emollient cream .05%). Neutrogena's 30-person professional sales force will cross-train with Ortho's to ensure complementary efforts in promoting Renova in conjunction with a companion Neutrogena product line.